Cleared Abbreviated

K131253 - PERIFLUX 6000

K131253 is an FDA 510(k) clearance for PERIFLUX 6000, manufactured by Perimed AB. The device is a Class 2 Anesthesiology device with product code LKD cleared through the Abbreviated 510(k) pathway after a 173-day FDA review.

K131253 · Perimed AB · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
173d
Days
Class 2
Risk

K131253 is an FDA 510(k) clearance for the PERIFLUX 6000. Classified as Monitor, Carbon-dioxide, Cutaneous (product code LKD), Class II - Special Controls.

Submitted by Perimed AB (Jarfalla, SE). The FDA issued a Cleared decision on October 22, 2013 after a review of 173 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2480 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Perimed AB devices

FDA 510(k) Submission Details - K131253

510(k) Number K131253 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2013
Decision Date October 22, 2013
Days to Decision 173 days
Submission Type Abbreviated
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 140d · This submission: 173d
Pathway characteristics
Standards-based clearance path.

LKD Device Classification - Class 2, Special Controls

Product Code LKD Monitor, Carbon-dioxide, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2480
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - LKD Monitor, Carbon-dioxide, Cutaneous

All 9
Devices cleared under the same product code (LKD) and FDA review panel - the closest regulatory comparables to K131253.
Sentec Digital Monitoring System (SDMS) tCOM+
K232516 · Sentec AG · May 2024
PHILIPS INTELLIVUE TCG10
K110474 · Philips Medizinsysteme Boeblingen GmbH, Cardiac AN · Sep 2011
TCM TOSCA MONITORING SYSTEM, TCM COMBIM MONITORING SYSTEM
K093154 · Radiometer Medical Aps · Feb 2010
TCM40 MONITORING SYSTEM
K043003 · Radiometer Medical Aps · Mar 2005
COROMETRICS TRANSCUTANEOUS TCPO2/CO2 MODULE
K980756 · Ge Medical Systems Information Technologies · Nov 1998
TCPO2 9260 MODULE - SYSTEM ATHENA
K913013 · S & W Medico Teknik · May 1994